N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for Parathyroid Hormone-Related Protein 1-34

International Journal of Pharmaceutics

Volumn 393, Issue 1-2, 2010, Pages 269-273

  Zhao, Sheng hao ^a   Wu, Xiao ting ^b   Guo, Wei chun ^a   Du, Yu min ^b   Yu, Ling ^a   Tang, Jin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Chitosan; EPTAC; HTCC; Nanoparticles; PTHrP1 34

Indexed keywords

N (2 HYDROXYL)PROPYL 3 TRIMETHYL AMMONIUM CHITOSAN CHLORIDE; NANOPARTICLE; PARATHYROID HORMONE[1-34]; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; MORPHOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 77953363802     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.034     Document Type: Article

References (28)

1. Bouillot P., Ubrich N., Sommer F., Duc T.M., Loeffler J.P., Dellacherie E. Protein encapsulation in biodegradable amphiphilic microspheres. Int. J. Pharm. 1999, 181:159-172.
2. Chen C., Koh A.J., Datta N.S., Zhang J., Keller E.T., Xiao G., Franceschi R.T., D'Silva N.J., McCauley L.K. Impact of the mitogen activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J. Biol. Chem. 2004, 279:29121-29129.
3. Clark M.A., Blair H., Liang L., Brey R.N., Brayden D., Hirst B.H. Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine 2001, 20:208-217.
4. Dang J.M., Leong K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug. Deliv. Rev. 2006, 58:487-499.
5. Douglas K.L., Piccirillo C.A., Tabrizian M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J. Control. Release 2006, 115:354-361.
6. Galindo-Rodriguez S.A., Allemann E., Fessi H., Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit. Rev. Ther. Drug Carrier Syst. 2005, 22:419-464.
7. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J. Control. Release 2006, 114:1-14.
8. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994, 236:1600-1603.
9. Hejazi R., Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 2003, 89:151-165.
10. Horwitz M.J., Tedesco M.B., Gundberg C., Garcia-Ocana A., Stewart A.F. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 2003, 88:569-575.
11. Janes K.A., Calvo P., Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug. Deliv. Rev. 2001, 47:83-97.
12. Jia Z., Shen D., Xu W. Synthesis and antibacterial of quaternary ammonium salt of chitosan. Carbohydr. Res. 2001, 333:1-6.
13. Knaul J.Z., Hudson S.M., Creber K.A.M. Improved mechanical properties of chitosan fibers. J. Appl. Polym. Sci. 1999, 72:1721-1731.
14. Kompella U.B., Lee V.H. Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Adv. Drug Del. Rev. 2001, 46:211-245.
15. Kotzé A.F., Thanou M.M., Luessen H.L., de Boer B.G., Verhoef J.C., Junginger H.E. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur. J. Pharm. Biopharm. 1999, 47:269-274.
16. Krauland A.H., Alonso M.J. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 2007, 340:134-142.
17. Lang, G., Wendel, H., Konard, E., 1990. Process for making quaternary chitosan derivatives for cosmetic agents. US Patent 4,921,949.
18. Li T., Shi X.W., Du Y.M., Tang Y.F. Quaternized chitosan/alginate nanoparticles for protein delivery. J. Biomed. Mater. Res. A. 2007, 83:383-390.
19. Lim S.H., Hudson S.M. Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group. Carbohydr. Res. 2004, 339:313-319.
20. Liu X.F., Guan Y.L., Yang D.Z., Li Z., Yao K.D. Antibacterial action of chitosan and carboxymethylated chitosan. J. Appl. Polym. Sci. 2001, 79:1324-1335.
21. Lowe P.J., Temple C.S. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 1994, 46:547-552.
22. Philbrick W.M., Wysolmerski J.J., Galbraith S., Holt E., Orloff J.J., Yang K.H., Vasavada R.C., Weir E.C., Broadus A.E., Stewart A.F. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol. Rev. 1996, 76:127-173.
23. Qin C.Q., Xiao L., Du Y.M., Shi X.W., Chen J.W. A new cross-linked quaternized-chitosan resin as the support of borohydride reducing agent. React. Funct. Polym. 2002, 50:165-171.
24. Stewart A.F., Cain R.L., Burr D.B., Jacob D., Turner C.H., Hock J.M. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. J. Bone Miner. Res. 2000, 15:1517-1525.
25. Suzuki K., Shinobu T., Saimoto H., Shigemasa Y., Oda D. New selectively N-substituted quaternary ammonium chitosan derivatives. Polym. J. 2000, 32:334-338.
26. Xu Y., Du Y., Huang R., Gao L. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 2003, 24:5015-5022.
27. Yu J.H., Du Y.M., Zheng H. Blend films of chitosan-gelation. J. Wuhan Univ. (Nat. Sci. Ed.). 1999, 45:440-444.
28. Zambaux M.F., Bonneaux F., Gref R., Dellacherie E., Vigneron C. Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles. Int. J. Pharm. 2001, 212:1-9.